Randomized Trial Outcomes for Pharmacist-Led Antibiotic Stewardship in Pneumonia

700 adult patients with hospital-acquired or ventilator-associated pneumonia were randomized in a controlled trial over 18 months. The dataset contains results from a study by Nawal Alsubaie, published in 2026, measuring the impact of clinical pharmacist interventions on antibiotic appropriateness and clinical outcomes.

Use Cases

• Compare appropriate_antimicrobial_prescription rates (77.6% vs. 60.8%) between intervention and control groups using statistical tests.
• Model the relationship between pharmacist intervention and reduced hospital_length_of_stay (mean reduction of 2.83 days).
• Analyze the correlation between intervention and total_antimicrobial_treatment_duration (11.98 vs. 13.45 days).
• Assess the impact on clinical_cure_rates (84.4% vs. 74.3%) and antimicrobial-related_adverse_events (8.7% vs. 14.1%).

Strengths

• Data originates from a prospective randomized controlled trial, a high-evidence study design.
• Contains specific, statistically significant outcome metrics (e.g., OR=2.26 for prescription appropriateness).
• Trial conducted over a defined 18-month period from April 2023 to October 2024.

Limitations

• The dataset is very small (19.3 KB), indicating it is likely a summary table, not the full patient-level trial data.
• Patient recruitment was from a single tertiary care hospital, limiting geographic and demographic generalizability.
• Specific column names and individual patient records are unavailable, restricting granular analysis.

Provenance

Source

figshare, author Nawal Alsubaie.

Collection Method

Prospective randomized controlled trial.

Time Range

April 2023 to October 2024 (18-month trial period).

Freshness

2026-04-07

Geography

A single tertiary care hospital (location unspecified).